Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Non-cash Items (2016 - 2017)

Agios Pharmaceuticals' Non-cash Items history spans 6 years, with the latest figure at $2.9 million for Q1 2017.

  • For Q1 2017, Non-cash Items rose 27.27% year-over-year to $2.9 million; the TTM value through Mar 2017 reached $2.9 million, up 27.27%, while the annual FY2016 figure was $2.5 million, 98.35% down from the prior year.
  • Non-cash Items reached $2.9 million in Q1 2017 per AGIO's latest filing, up from $2.5 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $360.9 million in Q4 2014 to a low of $1.6 million in Q3 2014.
  • Average Non-cash Items over 5 years is $87.8 million, with a median of $2.9 million recorded in 2013.
  • Peak YoY movement for Non-cash Items: soared 19159.11% in 2015, then plummeted 99.18% in 2016.
  • A 5-year view of Non-cash Items shows it stood at $76.2 million in 2013, then soared by 373.74% to $360.9 million in 2014, then tumbled by 57.45% to $153.6 million in 2015, then plummeted by 98.35% to $2.5 million in 2016, then grew by 15.09% to $2.9 million in 2017.
  • Per Business Quant, the three most recent readings for AGIO's Non-cash Items are $2.9 million (Q1 2017), $2.5 million (Q4 2016), and $110.1 million (Q3 2016).